AbbVie, Inc. (ABBV Quick QuoteABBV ) announced that it has submitted a regulatory application in the United States, seeking approval for its interleukin-23 (“IL-23”) inhibitor Skyrizi (risankizumab) as a potential treatment for moderate to severe Crohn’s disease (“CD”).
The regulatory filing seeks approval for Skyrizi both as a 600mg intravenous (“IV”) induction and 360mg subcutaneous (“SC”) maintenance therapy in patients aged 16 years and older with CD.
The filing is supported by data from three phase III studies —....More>>>
When it comes to selecting dividend stocks to buy, investors can take their pick: high yield stocks, blue chip stocks with safe payouts, stocks with high dividend growth rates, value stocks; the list goes on.
But selecting undervalued dividend stocks is particularly advantageous for a variety of reasons, not the least of which is that dividend yield is higher when a stock’s price is lower, as they move inversely.
Here are 3 undervalued dividend stocks to buy for high total returns:
Triton International (NYSE:TRTN) Perrigo Company (NYSE:PRGO) LyondellBasell Industries....More>>>